Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1.
J Cardiovasc Dev Dis
; 9(4)2022 Apr 09.
Article
em En
| MEDLINE
| ID: mdl-35448088
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article